Stuart Kupfer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Hypertrophic Cardiomyopathy

Psychometric Properties

Top Venues

European heart journal

Amyotrophic lateral sclerosis & frontotemporal degeneration

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline J Coats, Ahmad Masri, Michael E Nassif, Roberto Barriales Villa, Michael Arad, Nuno Cardim, Lubna Choudhury, Brian Lee Claggett, Hans-Dirk Düngen, Pablo García-Pavía, Albert A Hagège, James L Januzzi, Matthew Meng Yang Lee, Gregory D Lewis, Chang Sheng Ma, Martin S Maron, Zi Michael Miao, Michelle Michels, Iacopo Olivotto, Artur Oreziak, Anjali Tiku Owens, John A Spertus, Scott D Solomon, Jacob Tfelt Hansen, Marion van Sinttruije, Josef Veselka, Hugh C Watkins, Daniel L Jacoby, Polina German, Stephen B Heitner, Stuart Kupfer, Justin D Lutz, Fady I Malik, Lisa Meng, Amy Wohltman, Theodore P Abraham, null null
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. Journal of the American Heart Association (2024)
Caroline J Coats, Ahmad Masri, Michael E Nassif, Roberto Barriales Villa, Michael Arad, Nuno Cardim, Lubna Choudhury, Brian Lee Claggett, Hans-Dirk Düngen, Pablo García-Pavía, Albert A Hagège, James L Januzzi, Matthew Meng Yang Lee, Gregory D Lewis, Chang Sheng Ma, Martin S Maron, Zi Michael Miao, Michelle Michels, Iacopo Olivotto, Artur Oreziak, Anjali Tiku Owens, John A Spertus, Scott D Solomon, Jacob Tfelt Hansen, Marion van Sinttruije, Josef Veselka, Hugh C Watkins, Daniel L Jacoby, Polina German, Stephen B Heitner, Stuart Kupfer, Justin D Lutz, Fady I Malik, Lisa Meng, Amy Wohltman, Theodore P Abraham, null null
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. Journal of the American Heart Association 13 (15) (2024)
Caroline J Coats, Ahmad Masri, Roberto Barriales Villa, Theodore P Abraham, D Marshall Brinkley, Brian Lee Claggett, Albert A Hagège, Sheila M Hegde, Carolyn Y Ho, Ian J Kulac, Matthew M Y Lee, Martin S Maron, Iacopo Olivotto, Anjali T Owens, Scott D Solomon, Jacob Tfelt Hansen, Hugh C Watkins, Daniel L Jacoby, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Lisa Meng, Amy Wohltman, James L Januzzi, null null
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial. European heart journal (2024)
Jeremy M Shefner, Bill Jacobsen, Stuart Kupfer, Fady I Malik, Lisa Meng, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jeremy M Shefner, Ammar Al Chalabi, Jinsy A Andrews, Adriano Chio, Mamede de Carvalho, Bettina M Cockroft, Philippe Corcia, Philippe Couratier, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Terry D Heiman-Patterson, Robert David Henderson, Caroline Ingre, Carlayne E Jackson, Wendy Johnston, Noah Lechtzin, Albert C Ludolph, Nicholas J Maragakis, Timothy M Miller, Jesus S Mora, Susanne Petri, Zachary Simmons, Leonard H Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I Malik, Lisa Meng, Tyrell J Simkins, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Scott D Solomon, Brian L Claggett, Zi Michael Miao, Rafael Diaz, G Michael Felker, John J V McMurray, Marco Metra, Ramón Corbalán, Gerasimos S Filippatos, Assen R Goudev, Viatcheslav Mareev, Pranas Serpytis, Thomas Suter, Mehmet Birhan Yilmaz, Faiez Zannad, Stuart Kupfer, Stephen B Heitner, Fady I Malik, John R Teerlink
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. European heart journal 43 (23) (2022)
Marco Metra, Matteo Pagnesi, Brian Lee Claggett, Rafael Díaz, G Michael Felker, John Joseph Valentine McMurray, Scott D Solomon, Diana Bonderman, James C Fang, Cândida Fonseca, Eva Goncalvesova, Jonathan G Howlett, Jing Li, Eileen O'Meara, Zi Michael Miao, Siddique A Abbasi, Stephen B Heitner, Stuart Kupfer, Fady I Malik, John R Teerlink
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial. European heart journal (2022)